St. Charles, Missouri Clinical Trials

*Healthy Patient Studies

Pharma Medica Research, INC

Pharma Medica Research, INC is seeking Healthy participants for a research study.

Pharma Medica Research, INC

Healthy, Post-Menopausal Females

Attention Deficit/Hyperactivity Disorder (ADHD - Adults)

Midwest Research Group

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

View More »

St. Charles Psychiatric Associates - Midwest Research Group

A clinical trial to evaluate treatments using Dasotraline for patients with Attention Deficit Hyperactivity Disorder

St. Charles Psychiatric Associates - Midwest Research Group

A clinical trial to evaluate treatments using Metadoxine and Placebo for patients with Attention Deficit Hyperactivity Disorder (ADHD)

Autism

St. Charles Psychiatric Associates

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Binge Eating Disorder

St. Charles Psychiatric Associates - Midwest Research Group

A clinical trial to evaluate treatments using Dasotraline for patients with Binge Eating Disorder

St. Charles Psychiatric Associates - Midwest Research Group

A Phase 2/Phase 3 clinical study for patients with Binge Eating Disorder

Bipolar Disorder

Takeda Study Site

Clinical trial for Bipolar I

Bulimia

St. Charles Psychiatric Associates - Midwest Research Group

A Phase 2/Phase 3 clinical study for patients with Binge Eating Disorder

St. Charles Psychiatric Associates - Midwest Research Group

A clinical trial to evaluate treatments using Dasotraline for patients with Binge Eating Disorder

Chronic Obstructive Lung Disease

Midwest Chest Consultants, PC

A Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Monderate

COPD (Chronic Obstructive Pulmonary Disease)

Midwest Chest Consultants Updated

Clinical trial for Severe to Very Severe COPD

Midwest Chest Consultants, PC

A Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Monderate

Midwest Chest Consultants, PC

A Phase III, 52-week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease.

Midwest Chest Consultants, PC

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD).

View More »

GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Pearl Investigative Site

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Pearl Investigative Site

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Pearl Investigative Site

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Research Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Research Site Updated

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Depression

MMG

Does Your Child Have Depression?

View More »

Alkermes Investigational Site

A clinical trial seeking patients for a research study for the treatment of Major Depressive Disorder (MDD)

Forest Investigative Site 040

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Forest Investigative Site 055

A Phase 3 clinical study for patients with Major Depressive Disorder

St. Charles Psychiatric Associates

A Phase 3 clinical study for patients with Bipolar I Depression

Depression (Adolescent)

MMG

Does Your Child Have Depression?

Depression (Major/Severe)

MMG

Does Your Child Have Depression?

Heart Attack (Myocardial Infarction)

Research Site

A clinical trial seeking patients for a research study for the treatment of Cost Sharing, Acute Coronary Syndrome

Kidney Disease

St. Joseph Medical Center

A clinical trial seeking patients for a research study for the treatment of Contrast Induced Nephropathy

Lung Disease

GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Research Site Updated

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Schizophrenia and Schizoaffective Disorders

St. Charles Psychiatric Associates

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism